Skip to main content
Article thumbnail
Location of Repository

Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage

By Efty P Stavrou, Nicholas Buckley, Jake Olivier and Sallie-Anne Pearson
Topics: Medical Management
Publisher: BMJ Group
OAI identifier: oai:pubmedcentral.nih.gov:3358623
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group.
    2. Adherence with statins in a reallife setting is better when associated cardiovascular risk factors increase: a cohort study.
    3. (2011). Charlson and Rx-risk comorbidity indices were predictive of mortality in the Australian health care setting.
    4. (2005). Discontinuing cardiovascular medications at the end of life: lipid-lowering agents.
    5. (2006). Discontinuing lipid-lowering agents.
    6. Futile medication useinterminallyillcancerpatients.SupportCareCancer2009;17:745e8.
    7. (2008). Institute of Health and Welfare) & AACR (Australasian Association of Cancer Registries). Cancer in Australia: An Overview,
    8. (1999). New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther
    9. (2010). Non-cancer medications for patients with incurable cancer: time to stop and think.
    10. (2006). Physician practice in the discontinuation of statins among patients with advanced lung cancer.
    11. Polypharmacy in older adults with cancer.
    12. (2002). Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet
    13. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atheroscelrosis Prevention Study.
    14. (2003). Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med
    15. (2003). Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients.
    16. (2002). Statins in stroke prevention and carotid atherosclerosis: systematic review and up-todate meta-analysis. Stroke
    17. (2008). Statins in the last six months of life: a recognizable, life-limiting condition does not decrease their use.
    18. (2007). The broader implications of managing statins at the end of life.
    19. Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer 2011;19:1313e18.
    20. (2009). Validity of medication-based co-morbidity indicies in the Australian elderly population.
    21. (2007). Veterans’ Affairs Rehabilitation RaDG. Treatment Population Statistics.
    22. (2011). WHO Collaborating Centre for Drug Statistics Methodology. ATC/ DDD Index: C10AA HMG CoA Reductase Inhibitors. Oslo: World Health Organization,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.